Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Whitworth, Hilary ^a   Bhadel, Shriti ^a   Ivey, Melissa ^a   Conaway, Mark ^a,b   Spencer, Andrea ^c   Hernan, Ronald ^c   Holemon, Heather ^c   Gioeli, Daniel ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c Sigma Aldrich Co   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CITRON RHO INTERACTING KINASE; DIACYLGLYCEROL KINASE; DIACYLGLYCEROL KINASE DELTA; GALACTOKINASE 2; INTESTINAL CELL KINASE; MIXED LINEAGE KINASE 3; PHOSPHOTRANSFERASE; PROTEIN SERINE KINASE H1; SERINE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CASTRATION RESISTANT PROSTATE CANCER; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; GENE TARGETING; GENETIC SCREENING; GROWTH REGULATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANDROGENS; BLOTTING, WESTERN; CASTRATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPRECIPITATION; MALE; PHENOTYPE; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN KINASES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84862994069     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038950     Document Type: Article

References (48)

1. Gioeli D, (2005) Signal transduction in prostate cancer progression. Clin Sci (Lond) 108: 293-308.
2. Cunha GR, Ricke W, Thomson A, Marker PC, Risbridger G, et al. (2004) Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol 92: 221-36.
3. Burnstein KL, (2005) Regulation of androgen receptor levels: implications for prostate cancer progression and therapy. J Cell Biochem 95: 657-69.
4. Perez CA, (1985) Cancer of the Prostate. In: Cancer. Principles and Practice of Oncology. Philadelphia: J.B. Lippincott Company. pp. 929-964.
5. Gioeli DG, (2010) The promise of novel androgen receptor antagonists. Cell Cycle 9: 440-1.
6. Culig Z, Bartsch G, Hobisch A, (2002) Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth. Mol Cell Endocrinol. 197: 231-238.
7. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Hittmair A, et al. (1996) Regulation of prostatic growth and function by peptide growth factors. Prostate 28: 392-405.
8. Culig Z, Hobisch A, Bartsch G, Klocker H, (2000) Androgen receptor-an update of mechanisms of action in prostate cancer. Urological Research 28: 211-219.
9. Steiner H, Godoy-Tundidor S, Rogatsch H, Berger AP, Fuchs D, et al. (2003) Accelerated in Vivo Growth of Prostate Tumors that Up-Regulate Interleukin-6 Is Associated with Reduced Retinoblastoma Protein Expression and Activation of the Mitogen-Activated Protein Kinase Pathway. American Journal of Pathology 162: 655-663.
10. Nazareth LV, Weigel NL, (1996) Activation of the human androgen receptor through a protein kinase A signaling pathway. Journal of Biological Chemistry 271: 19900-19907.
11. Ikonen T, Palvimo JJ, Kallio PJ, Reinikainen P, Janne OA, (1994) Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology 135: 1359-1366.
12. Reinikainen P, Palvimo JJ, Janne OA, (1996) Effects of mitogens on androgen receptor-mediated transactivation. Endocrinology 137: 4351-7.
13. Weigel NL, Zhang Y, (1998) Ligand-independent activation of steroid hormone receptors. Journal of Molecular Medicine 76: 469-479.
14. Sadar MD, (1999) Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways. J Biol Chem 274: 7777-83.
15. Craft N, Shostak Y, Carey M, Sawyers CL, (1999) A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 5: 280-5.
16. Yeh S, Lin HK, Kang HY, Thin TH, Lin MF, et al. (1999) From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc Natl Acad Sci U S A 96: 5458-63.
17. Mellinghoff IK, Tran C, Sawyers CL, (2002) Growth inhibitory effects of the dual ErbB1/ErbB2 tyrosine kinase inhibitor PKI-166 on human prostate cancer xenografts. Cancer Research 62: 5254-5259.
18. Agus DB, Akita RW, Fox WD, Lewis GD, Higgins B, et al. (2002) Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth. Cancer Cell 2: 127-37.
19. Mellinghoff IK, Vivanco I, Kwon A, Tran C, Wongvipat J, et al. (2004) HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability. Cancer Cell 6: 517-27.
20. Steiner H, Godoy-Tundidor S, Rogatsch H, Berger AP, Fuchs D, et al. (2003) Accelerated in Vivo Growth of Prostate Tumors that Up-Regulate Interleukin-6 Is Associated with Reduced Retinoblastoma Protein Expression and Activation of the Mitogen-Activated Protein Kinase Pathway. American Journal of Pathology 162: 655-663.
21. Nazareth LV, Weigel NL, (1996) Activation of the human androgen receptor through a protein kinase A signaling pathway. Journal of Biological Chemistry 271: 19900-19907.
22. Ikonen T, Palvimo JJ, Kallio PJ, Reinikainen P, Janne OA, (1994) Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology 135: 1359-1366.
23. Reinikainen P, Palvimo JJ, Janne OA, (1996) Effects of mitogens on androgen receptor-mediated transactivation. Endocrinology 137: 4351-7.
24. Weigel NL, Zhang Y, (1998) Ligand-independent activation of steroid hormone receptors. Journal of Molecular Medicine 76: 469-479.
25. Berger R, Febbo PG, Majumder PK, Zhao JJ, Mukherjee S, et al. (2004) Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells. Cancer Res 64: 8867-75.
26. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, et al. (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50: 6075-6086. Accessed 13 December 2011.
27. Wang Q, Li W, Zhang Y, Yuan X, Xu K, et al. (2009) Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138: 245-56.
28. Gioeli D, Black BE, Gordon V, Spencer A, Kesler CT, et al. (2006) Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization. Mol Endocrinol 20: 503-15.
29. Gioeli D, (2005) Signal transduction in prostate cancer progression. Clin Sci (Lond) 108: 293-308.
30. Clark DE, Errington TM, Smith JA, Frierson HF, Weber MJ, et al. (2005) The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation. Cancer Res 65: 3108-16.
31. Galliher-Beckley AJ, Williams JG, Collins JB, Cidlowski JA, (2008) Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Molecular & Cellular Biology 28: 7309-22.
32. Gordon V, Bhadel S, Wunderlich W, Zhang J, Ficarro SB, et al. (2010) CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation. Mol Endocrinol 24: 2267-80.
33. Gallo KA, Johnson GL, (2002) Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat. Rev. Mol. Cell Biol 3: 663-672. Accessed 6 September 2011.
34. Gioeli D, Mandell JW, Petroni GR, Frierson HF, Weber MJ, (1999) Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res 59: 279-84.
35. Luo B, Regier D, Prescott S, Topham M, (2004) Diacylglycerol kinases. Cellular Signaling 16: 983-989.
36. Imai S, Yasuda S, Kai M, Kanoh H, Sakane F, (2009) Diacylglycerol kinase δ associates with receptor for activated C kinase 1, RACK1. Biochimica et Biophysica Acta 1791: 246-253.
37. Kraus S, Gioeli D, Vomastek T, Gordon V, Weber MJ, (2006) Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor. Cancer Res 66: 11047-54.
38. Cai J, Crotty TM, Reichert E, Carraway KL 3rd, Stafforini DM, et al (2010) Diacylglycerol kinase delta and protein kinase C(alpha) modulate epidermal growth factor receptor abundance and degradation through ubiquitin-specific protease 8. J. Biol. Chem 285: 6952-6959. Accessed 6 September 2011.
39. Fu Z, Larson KA, Chitta RK, Parker SA, Turk BE, et al. (2006) Identification of yin-yang regulators and a phosphorylation consensus for male germ cell-associated kinase (MAK)-related kinase. Mol. Cell. Biol 26: 8639-8654. Accessed 18 August 2011.
40. Ma A-H, Xia L, Desai SJ, Boucher DL, Guan Y, et al. (2006) Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells. Cancer Res 66: 8439-8447. Accessed 18 August 2011.
41. Desmots F, Russell HR, Lee Y, Boyd K, McKinnon PJ, (2005) The reaper-binding protein scythe modulates apoptosis and proliferation during mammalian development. Mol. Cell. Biol 25: 10329-10337. Accessed 18 August 2011.
42. Shandala T, Gregory SL, Dalton HE, Smallhorn M, Saint R, (2004) Citron kinase is an essential effector of the Pbl-activated Rho signalling pathway in Drosophila melanogaster. Development 131: 5053-5063. Accessed 18 August 2011.
43. Thoden JB, Holden HM, (2005) The molecular architecture of human N-acetylgalactosamine kinase. J. Biol. Chem 280: 32784-32791. Accessed 18 August 2011.
44. Zeidan Q, Hart GW, (2010) The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J. Cell. Sci 123: 13-22. Accessed 18 August 2011.
45. Brede G, Solheim J, Prydz H, (2002) PSKH1, a novel splice factor compartment associated serine kinase. Nucleic Acids Research 30: 5301-5309.
46. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, et al. (1994) Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54: 2577-81.
47. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, et al. (2000) LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 44: 91-103.
48. Gioeli D, Black BE, Gordon V, Spencer A, Kesler CT, et al. (2006) Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization. Mol Endocrinol 20: 503-15.